Editorial: chronic DILI and HILI-corticosteroid plus glycyrrhizin as standard therapy? Authors' reply

Aliment Pharmacol Ther. 2022 Jul;56(1):168-169. doi: 10.1111/apt.16983.

Authors

Jia-Bo Wang^{1

2}, Ang Huang¹, Yijin Wang^{3

4}, Dong Ji¹, Zhengsheng Zou¹

Affiliations

¹ Senior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
² School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
³ School of Medicine, Southern University of Science and Technology (SUSTech), Shenzhen, Guangdong, China.
⁴ Department of Pathology and Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.

PMID: 35689319
DOI: 10.1111/apt.16983

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenal Cortex Hormones
Chemical and Drug Induced Liver Injury*
Drugs, Chinese Herbal*
Glycyrrhizic Acid / therapeutic use
Humans

Substances

Adrenal Cortex Hormones
Drugs, Chinese Herbal
Glycyrrhizic Acid